Drug-induced or toxic liver disease with chronic hepatitis

Description

This is the chronic form of drug-induced liver injury that almost always depends on continued exposure to the agent, and is characterised by interface hepatitis, bridging necrosis, and fibrosis.

Exclusions from above levels

DB94 – Alcoholic liver disease
DB98.5 – Budd-Chiari syndrome
ME10.1 – Unspecified jaundice

Show allHide

01 – Certain infectious or parasitic diseases
02 – Neoplasms
05 – Endocrine, nutritional or metabolic diseases
06 – Mental, behavioural or neurodevelopmental disorders
18 – Complications of pregnancy, childbirth and the puerperium
22 – Injury, poisoning or certain other consequences of external causes

Child codes

DB95.10 – Drug-induced or toxic liver disease with chronic hepatitis with cirrhosis
DB95.11 – Drug-induced or toxic liver disease with chronic hepatitis without cirrhosis
DB95.1Z – Drug-induced or toxic liver disease with chronic hepatitis, unspecified

Sibling codes

DB95.0 – Drug-induced or toxic liver disease with acute hepatic necrosis or acute hepatitis
DB95.2 – Drug-induced or toxic liver disease with cholestasis
DB95.3 – Drug-induced or toxic liver disease with fatty liver
DB95.4 – Drug-induced or toxic liver disease with granulomatous hepatitis
DB95.5 – Drug-induced or toxic liver disease with fibrosis or cirrhosis of liver
DB95.6 – Drug-induced or toxic liver disease with vascular disorders of the liver
DB95.7 – Drug-induced or toxic liver disease with liver tumours
DB95.Y – Other specified drug-induced or toxic liver disease
DB95.Z – Drug-induced or toxic liver disease, unspecified

Foundation entity

Drug-induced or toxic liver disease with chronic hepatitis – http://id.who.int/icd/entity/180194892

Allowed postcoordination axes

Part of: DB95: Drug-induced or toxic liver disease › 13: Diseases of the digestive system